StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Goldenwell Biotech's total debt was $176.09K at Mar 31, 2025. For fiscal 2024 it was $173.99K, up 275.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$173.99K+275.5%
FY2023Dec 31, 2023$46.34K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025$176.09K–
Q4 FY2024Dec 31, 2024$173.99K–
Q4 FY2023Dec 31, 2023$46.34K–

More Goldenwell Biotech figures

See a number that looks wrong?